Cargando…

Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States

Detalles Bibliográficos
Autores principales:	Stokley, Shannon, Jeyarajah, Jenny, Yankey, David, Cano, Maria, Gee, Julianne, Roark, Jill, Curtis, C. Robinette, Markowitz, Lauri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	U.S. Centers for Disease Control 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779422/ https://www.ncbi.nlm.nih.gov/pubmed/25055185

Ejemplares similares

Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States
por: Stokley, Shannon, et al.
Publicado: (2013)

National and State Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2012
por: Curtis, C. Robinette, et al.
Publicado: (2013)

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014
por: Reagan-Steiner, Sarah, et al.
Publicado: (2015)

Postlicensure surveillance of human papillomavirus vaccine using the Vaccine Adverse Event Reporting System, 2006–2017
por: Neha, Reddy, et al.
Publicado: (2020)

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2013
por: Elam-Evans, Laurie D., et al.
Publicado: (2014)

Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13–17 by metropolitan statistical area (MSA) status, National Immunization Survey – Teen, 2013 – 2017
por: Walker, Tanja Y., et al.
Publicado: (2019)

Detection of Novel Rotavirus Strain by Vaccine Postlicensure Surveillance
por: Weinberg, Geoffrey A., et al.
Publicado: (2013)

Postlicensure herpes zoster vaccine effectiveness: systematic review protocol
por: Mbinta, James F, et al.
Publicado: (2021)

Insurance reimbursements for human papillomavirus vaccination in the private sector, 2007–2014()
por: Tsai, Yuping, et al.
Publicado: (2019)

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2017
por: Walker, Tanja Y., et al.
Publicado: (2018)

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018
por: Walker, Tanja Y., et al.
Publicado: (2019)

National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2021
por: Pingali, Cassandra, et al.
Publicado: (2022)

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
por: Petrosky, Emiko, et al.
Publicado: (2015)

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019
por: Elam-Evans, Laurie D., et al.
Publicado: (2020)

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2016
por: Walker, Tanja Y., et al.
Publicado: (2017)

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2020
por: Pingali, Cassandra, et al.
Publicado: (2021)

Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018
por: Hesse, Elisabeth M., et al.
Publicado: (2019)

Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey–Teen, United States, 2022
por: Pingali, Cassandra, et al.
Publicado: (2023)

Vaccination Coverage Among Adults, Excluding Influenza Vaccination — United States, 2013
por: Williams, Walter W., et al.
Publicado: (2015)

Human Papillomavirus Vaccination Estimates Among Adolescents in the Mississippi Delta Region: National Immunization Survey‑Teen, 2015–2017
por: Yankey, David, et al.
Publicado: (2020)

Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA
por: Link-Gelles, Ruth, et al.
Publicado: (2017)

1050 Evaluation of syncope and related events following vaccination with quadrivalent human papillomavirus vaccine (2006-2013)
por: Lievano, Fabio, et al.
Publicado: (2014)

A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016
por: Irving, Stephanie A., et al.
Publicado: (2022)

Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data
por: Nelson, Jennifer C, et al.
Publicado: (2022)

Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents
por: VanWormer, Jeffrey J., et al.
Publicado: (2017)

Sociodemographic and clinical correlates of human papillomavirus vaccine attitudes and receipt among Wisconsin adolescents
por: Hanson, Kayla E., et al.
Publicado: (2019)

Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
por: Gee, Julianne, et al.
Publicado: (2016)

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016
por: Gallagher, Katherine E., et al.
Publicado: (2017)

Licensing Examination and Crash Outcomes Postlicensure in Young Drivers
por: Walshe, Elizabeth A., et al.
Publicado: (2022)

Human papillomavirus vaccination coverage in Northeast Brazil, 2013-2021: a descriptive study
por: von Glehn, Mateus de Paula, et al.
Publicado: (2023)

Varicella Vaccination Coverage among Adolescents Ages 13–17 Years, United States, National Immunization Survey, 2007–2014
por: Leung, Jessica, et al.
Publicado: (2017)

Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review
por: Mesfin, Yonatan Moges, et al.
Publicado: (2019)

Statistical Power for Postlicensure Medical Product Safety Data Mining
por: Maro, Judith C., et al.
Publicado: (2017)

Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination
por: Shing, Jaimie Z., et al.
Publicado: (2019)

National, State, and Selected Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2013
por: Elam-Evans, Laurie D., et al.
Publicado: (2014)

2013 Trends in anogenital warts incidence: Potential impact of human papillomavirus vaccination, TennCare 2006–2015
por: Shing, Jaimie Z., et al.
Publicado: (2018)

Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
por: Jemal, Ahmedin, et al.
Publicado: (2013)

Global Routine Vaccination Coverage, 2013
por: Harris, Jennifer B., et al.
Publicado: (2014)

Cost-effectiveness of Human Papillomavirus Vaccination in the United States
por: Chesson, Harrell W., et al.
Publicado: (2008)

Global rotavirus vaccine introductions and coverage: 2006 – 2016
por: Abou-Nader, Alice J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fv8f1cung7s4jtf9bbv2bva2ib